Abstract

The onset of obesity-linked type 2 diabetes (T2D) is marked by an eventual failure in pancreatic β-cell function and mass that is no longer able to compensate for the inherent insulin resistance and increased metabolic load intrinsic to obesity. However, in a commonly used model of T2D, the db/db mouse, β-cells have an inbuilt adaptive flexibility enabling them to effectively adjust insulin production rates relative to the metabolic demand. Pancreatic β-cells from these animals have markedly reduced intracellular insulin stores, yet high rates of (pro)insulin secretion, together with a substantial increase in proinsulin biosynthesis highlighted by expanded rough endoplasmic reticulum and Golgi apparatus. However, when the metabolic overload and/or hyperglycemia is normalized, β-cells from db/db mice quickly restore their insulin stores and normalize secretory function. This demonstrates the β-cell's adaptive flexibility and indicates that therapeutic approaches applied to encourage β-cell rest are capable of restoring endogenous β-cell function. However, mechanisms that regulate β-cell adaptive flexibility are essentially unknown. To gain deeper mechanistic insight into the molecular events underlying β-cell adaptive flexibility in db/db β-cells, we conducted a combined proteomic and post-translational modification specific proteomic (PTMomics) approach on islets from db/db mice and wild-type controls (WT) with or without prior exposure to normal glucose levels. We identified differential modifications of proteins involved in redox homeostasis, protein refolding, K48-linked deubiquitination, mRNA/protein export, focal adhesion, ERK1/2 signaling, and renin-angiotensin-aldosterone signaling, as well as sialyltransferase activity, associated with β-cell adaptive flexibility. These proteins are all related to proinsulin biosynthesis and processing, maturation of insulin secretory granules, and vesicular trafficking-core pathways involved in the adaptation of insulin production to meet metabolic demand. Collectively, this study outlines a novel and comprehensive global PTMome signaling map that highlights important molecular mechanisms related to the adaptive flexibility of β-cell function, providing improved insight into disease pathogenesis of T2D.

Highlights

  • Characterization of Signaling Pathways Associated with Pancreatic ␤-cell Adaptive Flexibility in Compensation of Obesity-linked Diabetes in db/db Mice*□S

  • 1 The abbreviations used are: T2D, type 2 diabetes; PTMomics, post-translational modification specific proteomic; db/db, obese leptin receptor-deficient mice; WT, C57BL/6J wild type; SA, formerly sialylated N-linked glycosylation; PRM, parallel reaction monitoring; CV, coefficient of variation; Tio2, titanium dioxide; SIMAC, deglycosylation step using the sequential elution from IMAC; nLC-MS/MS, nanoflow liquid chromatography-tandem mass spectrometry; TMT, tandem mass tags; FDR, false discovery rate; GO, gene ontology; N, normal wild type mouse islet, normal 5.6 mM glucose (NG), normal islets with 5.6mM glucose; D, freshly isolated db/db mouse islet; DG, db/db mouse islet with 5.6mM glucose; CIM, circular interactome map; UPR, unfolded protein response

  • To determine whether proteins or modification sites were significantly regulated in freshly isolated db/db mouse islet (D) compared with normal WT (N), we examined regulated proteins, phosphopeptides, or SA glycopeptides between D and N that were significantly increased or decreased (Ն 2.0 fold or Յ 0.5 fold with CV% Յ 30% and/or z-test for adjusted p value Ͻ 0.05) and altered in the same direction of change in all of the identified replicates

Read more

Summary

Graphical Abstract

An unbiased quantitative profiling of the protein expression, phosphorylation, and sialylation events that occur upon ␤-cell adaptive flexibility during the transition from hyperglycemia to euglycemia was assessed in islets from db/db and WT mice before and after ␤-cell rest. If the glucose concentration is lowered in an insulin-independent manner, and/or insulin resistance is alleviated, the in vivo demand for insulin is lowered and endogenous ␤-cells recover normal insulin secretory capacity and function [7, 9] These “restored” ␤-cells are characterized by a restoration of mature insulin secretory granule intracellular stores and insulin secretory capacity, slowing of (pro)insulin production accompanied by normalized endoplasmic reticulum (RER) and Golgi apparatus morphologies, recovered mitochondrial structure and morphology, and re-establishment of normal biphasic insulin secretion in response to glucose (6 –9). We have expanded the analysis of quantitative proteomics and PTMomics (phosphorylation and sialylated N-linked glycosylation) data to elucidate novel molecular processes underlying functional compensation of ␤-cells in db/db mice and their subsequent recovery following exposure

The abbreviations used are
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call